Clínica Baviera, S.A. Reports Earnings Results for the Fourth Quarter and Full Year of 2016
February 21, 2017
Share
Clínica Baviera, S.A. reported earnings results for the fourth quarter and full year of 2016. For the year, the company reported net revenues of €91.572 million against €85.527 million a year ago. EBITDA was €16.484 million against €11.382 million a year ago. EBIT was €11.606 million against €6.512 million a year ago. Profit before taxes was €11.343 million against €6.651 million a year ago. Net profit was €7.945 million against €4.839 million a year ago. CAPEX were €6.617 million and net debt position as on December 31, 2016 was €4.828 million against €1.373 million a year ago. Cash flow from operations was €13.547 million.
For the fourth quarter, the company reported revenue of €24.421 million and EBITDA of €4.241 million.
Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.
CLÍNICA BAVIERA, S.A. 
